Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Thematic Sector
  • Asset Class: Equity
  • Geographic Focus: Global

Challenge Funds - Challenge Counter Cyclical Fund

+ Add to Watchlist

MEDHCEL:ID

5.46 EUR 0.04 0.79%

As of 00:59:30 ET on 03/05/2015.

Snapshot for Challenge Funds - Challenge Counter Cyclical Fund (MEDHCEL)

Year To Date: +12.12% 3-Month: +12.66% 3-Year: +18.85% 52-Week Range: 3.97 - 5.46
1-Month: +4.44% 1-Year: +32.30% 5-Year: +13.80% Beta vs MSGUHC: 0.77

Mutual Fund Chart for MEDHCEL

No chart data available.
  • MEDHCEL:ID 5.46
  • 1M
  • 1Y
Interactive MEDHCEL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for MEDHCEL

Challenge Funds - Challenge Counter Cyclical Fund is a UCITS certified open-end fund incorporated in Ireland. The Fund's objective is long-term capital appreciation through investment in a diversified portfolio of leading healthcare or sector related stocks listed or traded on Recognized Exchanges.

Inception Date: 11-30-2000 Telephone: Not Disclosed
Managers: -
Web Site: www.mediolanum.ie

Fundamentals for MEDHCEL

NAV (on 2015-03-05) 5.46
Assets (M) (on 2015-03-05) 746.68
Fund Leveraged N
Minimum Investment -
Minimum Subsequent Investment -

Dividends for MEDHCEL

No dividends reported

Fees & Expenses for MEDHCEL

Front Load 5.00
Back Load 0.00
Current Mgmt Fee 1.65
Redemption Fee 0.00
12b1 Fee -
Expense Ratio -

Top Fund Holdings for MEDHCEL

Filing Date: 06/30/2014
Name Position Value % of Total
Johnson & Johnson 216,270 16,646,154 2.838%
Health Care Select Sector SPDR 339,360 15,193,516 2.590%
Nestle SA 246,776 13,961,772 2.380%
Procter & Gamble Co/The 207,935 12,045,763 2.053%
Roche Holding AG 53,756 11,647,769 1.986%
Novartis AG 175,931 11,647,518 1.986%
Verizon Communications Inc 316,448 11,441,821 1.950%
Pfizer Inc 487,867 10,611,791 1.809%
AT&T Inc 397,976 10,331,242 1.761%
Merck & Co Inc 225,164 9,496,488 1.619%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil